#189 The OI Show - What the FDA was thinking when it came to Sydnexis and Atropine with Dr. Alan Glazier and Dr. Mile Brujic
Impossibile aggiungere al carrello
Rimozione dalla Lista desideri non riuscita.
Non è stato possibile aggiungere il titolo alla Libreria
Non è stato possibile seguire il Podcast
Esecuzione del comando Non seguire più non riuscita
#189 The OI Show - What the FDA was thinking when it came to Sydnexis and Atropine with Dr. Alan Glazier and Dr. Mile Brujic
-
Letto da:
-
Di:
A proposito di questo titolo
Send us a text
- Petition · Urgent Call for U.S. Children to Have Access to an FDA-Approved Low-Dose Atropine - United States · Change.org
About Dr. Glazier
Dr. Glazier is the founder and visionary behind FluoreSCENE Group, the eye care industry's most highly engaged media org. He is founder of Shady Grove Eye and Vision Care, a large medical model practice in Rockville, MD. Honors and accomplishments include selection as one of the 50 most influential optometrists by his peers, 250 “innovators in Optometry by PCON magazine, Maryland Optometrist of the year in 2017.
Dr Glazier was the commencement speaker for the New England College of Optometry in 2019 and awarded a Presidential medal by the institution. In 2020 he was appointed to the Board of Trustees of the institution. In 2021 and 2022 he was named in the top 3 of “America’s Best Eye Doctors” by Newsweek Magazine. In 2023 he was presented the Distinguished Service Award by the American Optometric Association. He has presented over 100 invited lectures, written numerous journal articles, authored 2 books, has 11 issued and 4 pending patents in ophthalmology and computer science and authored 1 peer reviewed publication in the journal Clinical Ophthalmology. Dr Glazier consults with numerous companies inside and outside the industry, sits on several advisory boards and has been interviewed on CNN, NBC, CBS, Entrepreneur and INC magazines. He resides in Rockville Maryland